A Phase 1 Study of Single Agent Pexidartinib in Asian Subjects With Advanced Solid Tumors
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007347/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a Phase I, non-randomized, open-label, multiple dose study of pexidartinib in Asian
subjects with advanced solid tumors. The study will be conducted in a dose escalation to
assess the safety and tolerability, pharmacokinetics (PK) and pharmacodynamics (PD), and
preliminary antitumor activity of pexidartinib.
提供机构：
Vivli
创建时间：
2021-08-24
